[EN] INHIBITORS OF APOL1 AND USE OF THE SAME<br/>[FR] INHIBITEURS D'APOL1 ET LEUR UTILISATION
申请人:VERTEX PHARMA
公开号:WO2021252859A1
公开(公告)日:2021-12-16
The disclosure provides at least one compound, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of formula (I), deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of making and using the same, including use in treating APOL1 mediated kidney disease.
A carbamoyl-substituted nitrileoxide was generated upon treatment of easily available 2-methyl-4-nitro-3-isoxazolin-5(2H)-one with THF (not dried); the reaction proceeded efficiently even in the absence of any special reagents and reaction conditions. The nitrileoxide caused 1,3-dipolarcycloaddition with common aliphatic nitriles or electron-rich aromatic nitriles to afford 3-functionalized 1,2